Schroder Investment Management Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
60,564
-119
| -0.2% | -$3.76K | ﹤0.01% | 917 |
|
|
2025
Q1 | $2.01M | Buy |
+60,683
| New | +$2.01M | ﹤0.01% | 902 |
|
|
2024
Q4 | – | Sell |
-29,579
| Closed | -$1.16M | – | 1218 |
|
|
2024
Q3 | $1.16M | Hold |
29,579
| – | – | ﹤0.01% | 1012 |
|
|
2024
Q2 | $892K | Sell |
29,579
-147,875
| -83% | -$4.46M | ﹤0.01% | 1048 |
|
|
2024
Q1 | $5.96M | Sell |
177,454
-50,046
| -22% | -$1.68M | 0.01% | 750 |
|
|
2023
Q4 | $7.35M | Buy |
+227,500
| New | +$7.35M | 0.01% | 690 |
|
|
2023
Q3 | – | Sell |
-106,527
| Closed | -$3.75M | – | 1217 |
|
|
2023
Q2 | $3.75M | Sell |
106,527
-151,861
| -59% | -$5.34M | 0.01% | 836 |
|
|
2023
Q1 | $8.44M | Buy |
258,388
+117,404
| +83% | +$3.83M | 0.01% | 665 |
|
|
2022
Q4 | $7.77M | Buy |
140,984
+74,422
| +112% | +$4.1M | 0.01% | 680 |
|
|
2022
Q3 | $2.95M | Buy |
+66,562
| New | +$2.95M | ﹤0.01% | 871 |
|
|
2022
Q1 | – | Sell |
-33,469
| Closed | -$1.43M | – | 1460 |
|
|
2021
Q4 | $1.43M | Buy |
+33,469
| New | +$1.43M | ﹤0.01% | 983 |
|